|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Role of Helicobacter pylori infection in gastric carcinogenesis:Current knowledge and future directions显示文摘Helicobacter pylori(H. pylori) plays a role in the patho-genesis of gastric cancer. The outcome of the infection depends on environmental factors and bacterial and host characteristics. Gastric carcinogenesis is a multistep process that is reversible in the early phase of mucosal damage, but the exact point of no return has not been identified. Therefore, two main therapeutic strategies could reduce gastric cancer incidence:(1) eradication of the already present infection; and(2) immunization(prior to or during the course of the infection). The success of a gastric cancer prevention strategy depends on timing because the prevention strategy must be introduced before the point of no return in gastric carcinogenesis. Although the exact point of no return has not been identified, infection should be eradicated before severe atrophy of the gastric mucosa develops. Eradication therapy rates remain suboptimal due to increasing H. pylori resistance to antibiotics and patient noncompliance. Vaccination against H. pylori would reduce the cost of eradication therapies and lower gastric cancer incidence. A vaccine against H. pylori is still a research challenge. An effective vaccine should have an adequate route of delivery, appropriate bacterial antigens and effective and safe adjuvants. Future research should focus on the development of rescue eradication therapy protocols until an efficacious vaccine against the bacterium becomes available. | Aleksandra Sokic-Milutinovic Tamara Alempijevic Tomica Milosavljevic | 2015 | World Journal of Gastroenterology2015，21，41： | 30 |
| 2 | Drug-induced liver injury: Do we know everything?显示文摘Interest in drug-induced liver injury(DILI) has dramatically increased over the past decade, and it has become a hot topic for clinicians, academics, pharmaceutical companies and regulatory bodies. By investigating the current state of the art, the latest scientific findings, controversies, and guidelines, this review will attempt to answer the question: Do we know everything? Since the first descriptions of hepatotoxicity over 70 years ago, more than 1000 drugs have been identified to date, however, much of our knowledge of diagnostic and pathophysiologic principles remains unchanged. Clinically ranging from asymptomatic transaminitis and acute or chronic hepatitis, to acute liver failure, DILI remains a leading causes of emergent liver transplant. The consumption of unregulated herbal and dietary supplements has introduced new challenges in epidemiological assessment and clinician management. As such, numerous registries have been created, including the United States Drug-Induced Liver Injury Network, to further our understanding of all aspects of DILI. The launch of Liver Tox and other online hepatotoxicity resources has increased our awareness of DILI. In 2013, the first guidelines for the diagnosis and management of DILI, were offered by the Practice Parameters Committee of the American College of Gastroenterology, and along with the identification of risk factors and predictors of injury, novel mechanisms of injury, refined causality assessment tools, and targeted treatment options have come to define the current state of the art, however, gaps in our knowledge still undoubtedly remain. | Tamara Alempijevic Simon Zec Tomica Milosavljevic | 2017 | World Journal of Hepatology2017，9，10： | 13 |
| 3 | Biochemical markers for non-invasive assessment of disease stage in patients with primary biliary cirrhosis显示文摘AIM: To evaluate different biochemical markers and their ratios in the assessment of primary biliary cirrhosis (PBC) stages. METHODS: This study included 112 patients with PBC who underwent a complete clinical investigation. We analyzed the correlation (Spearman's test) between ten biochemical markers and their ratios with different stages of PBC. The discriminative values were compared using areas under receiver operating characteristic (ROC) curves. RESULTS: The mean age of patients included in the study was 53.88 ± 10.59 years, including 104 females and 8 males. We found a statistically significant correlation between PBC stage and Aspartate aminotransferase (AST), Alanine aminotransferase (ALT) to platelet ratio (APRI), ALT/platelet count, AST/ALT, ALT/AST and ALT/Cholesterol ratios, with the values of Spearman's rho of 0.338, 0.476, 0.404, 0.356, 0.351 and 0.325, respectively. The best sensitivity and specificity was shown for AST/ALT, with an area under ROC of 0.660. CONCLUSION: Biochemical markers and their ratios do correlate with different sensitivity to and specificity of PBC disease stage. The use of biochemical markers and their ratios in clinical evaluation of PBC patients may reduce, but not eliminate, the need for liver biopsy. | Tamara Alempijevic Miodrag Krstic Rada Jesic Ivan Jovanovic Aleksandra Sokic Milutinovic Nada Kovacevic Slobodan Krstic Dragan Popovic | 2009 | World Journal of Gastroenterology2009，15，5： | 4 |
| 4 | Right liver lobe/albumin ratio:Contribution to non-invasive assessment of portal hypertension显示文摘瞄准:学习价值生物化学并且在存在的预言和食道的静脉曲张的尺寸的 ultraso-nographic 参数。方法:学习包括经历了一个完全的生物化学的工作在上面的选择肝脏硬化症的病人,上面内视镜的 digestive 和 ultrasonographic 考试。白朊 / 权利肝脑叶直径和血小板计数 / 脾直径比率是计算的。在食道的静脉曲张的计算比率和存在和度之间的关联被评估。结果:94 个题目(62 男性, 32 女性) ,与 52.32 +/- 的吝啬的年龄 13.60 年,被学习。孩子呸班 A 占了 42.6% ,班 B 37.2% ,而班 C 20.2% 。,食道的静脉曲张(OE ) 没被上面的消化内视镜检查法在 24.5% 表明我在 22.3% 病人,被发现的 OE 等级在 33.0% 分级 II,在 16.0% 分级 III,并且分级在 4.3% 的 IV。正确的肝脑叶直径 / 白朊比率的吝啬的价值是 5.51 +/- 1.82 (从 2.76 ~ 11.44 的范围) 当吝啬的血小板计数 / 脾直径比率是 1017.75 +/- 时 729.36 (从 117.39 ~ 3362.50 的范围) 分别地。统计上重要的关联被枪兵在 OE 等级和计算比率之间的测试证明。P 价值是 0.481 并且 -0.686, 分别地。结论:正确的肝脑叶直径 / 白朊和血小板计数 / 脾直径比率是提供对食道的静脉曲张,并且他们与肝肝硬化在病人分级的存在的决心恰当的精确信息的非侵略的参数。 | Tamara Alempijevic Vladislava Bulat Srdjan Djuranovic Nada Kovacevic Rada Jesic Dragan Tomic Slobodan Krstic Miodrag Krstic | 2007 | World Journal of Gastroenterology2007，13，40： | 4 |
| 5 | Gastric multicentric glo- mangioma:a case report of this rare cause of abdominal pain显示文摘 | Alempijevic T Knezevic S Knezevic D | 2008 | Med Sci Monit2008，14，1： | 1 |
| 6 | Sensor Registration and Calibration Using Moving Targets显示文摘 | Kodagoda K R S Alempijevic A Underwood J | | 0，，01： | 1 |
| 7 | Double common bile duct: A case report显示文摘Double common bile duct (DCBD) is a rare congenital anomaly in which two common bile ducts exist. One usually has normal drainage into the papilla duodeni major and the other usually named accessory common bile duct (ACBD) opens in different parts of upper gastrointestinal tract (stomach, duodenum, ductus pancreaticus or septum). This anomaly is of great importance since it is often associated with biliary lithiasis, choledochal cyst, anomalous pancreaticobiliary junction (APBJ) and upper gastrointestinal tract malignancies. We recently recognized a rare case of DCBD associated with APBJ with lithiasis in better developed common bile duct. The opening site of ACBD was in the pancreatic duct. The anomaly was suspected by transabdominal ultrasonography and finally confirmed by endoscopic retrograde cholangiopancreatography (ERCP) followed by endoscopic sphincterotomy and stone extraction. According to the literature, the existence of DCBD with the opening of ACBD in the pancreatic duct is most frequently associated with APBJ and gallbladder carcinoma. In case of DCBD, the opening site of ACBD is of greatest clinical importance because of its close implications with concomitant pathology. The adequate diagnosis of this rare anomaly is significant since the operative complications may occur in cases with DCBD which is not recognized prior to surgical treatment. | Srdjan P Djuranovic Milenko B Ugljesic Nenad S Mijalkovic Viktorija A Korneti Nada V Kovacevic Tamara M Alempijevic Slaven V Radulovic Dragan V Tomic Milan M Spuran | 2007 | World Journal of Gastroenterology2007，13，27： | 1 |
| 8 | Amniotic fluid embolism-apropos two consecutive cases 显示文摘 | Jecmenica D Baralic I Alempijevic D et aI | 2011 | J Forensic Sci2011，561，： | 1 |
| 9 | Gastric multicentric glomangioma : A case report of this rare cause of abdominal pain显示文摘 | Alempijevic T Knezevic S Knezevic D | 2008 | Med Sci Monit2008，14，1： | 1 |
| 10 | Clinieopathologieal characteristics of Barrett's carcinoma, cardia carcinoma type II and distal gastric carcinoma: influence of observed parameters on the five-year postoperative survival of patients 显示文摘 | JOVANOVIC I ALEMPIJEVIC T MILOSAVLJEVIC T | 2009 | Srp Arh Celok Lek2009，137，56： | 1 |
| 11 | The role of fecal calprotectin in assessment of hepatic encephalopathy in patients with liver cirrhosis 显示文摘 | Alempijevic T Stulic M Popovic D | 2014 | Acta Gastroenterol Belg2014，77，3： | 1 |
| 12 | Gastric multicen-tric glomangioma : a case report of this rare cause of abdominalpain显示文摘 | Alempijevic T Knezevic S Knezevic D | 2008 | Med Sci Monit2008，14，： | 1 |
| 13 | Endoskopischer Ultraschall für die Differenzialdiagnose von L?sionen des Zw?lffingerdarms显示文摘 | A. Pavlovic Markovic T. R?sch T. Alempijevic M. Krstic D. Tomic P. Dugalic A. Sokic Milutinovic M. Bulajic | 2012 | Ultraschall in Med2012，，07： | 1 |
| 14 | Validation of the chronic liver disease questionnaire in Serbian patients显示文摘AIM:To translate into Serbian and to investigate the validity of the cross-culturally adapted the chronic liver disease questionnaire(CLDQ).METHODS:The questionnaire was validated in 103 consecutive CLD patients treated between October 2009 and October 2010 at the Clinic for Gastroenterology,Clinical Centre of Serbia,Belgrade(Serbia).Exclusion criteria were:age < 18 years,psychiatric disorders,acute complications of CLD(acute liver failure,variceal bleeding,and spontaneous bacterial peritonitis),hepatic encephalopathy(grade > 2)and liver transplantation.Evaluation of the CLDQ was done based on the following parameters:(1)acceptance is shown by the proportion of missing items;(2)internal reliabilities were assessed for multiple item scales by using Cronbach alpha coefficient;and(3)in order to assess whether the allocation of items in the domain corresponds to their distribution in the original questionnaire(construction validity),an exploratory factor analysis was conducted.Discriminatory validity was determined by comparing the corresponding CLDQ score/sub-score in patients with different severity of the diseases.RESULTS:The Serbian version of CLDQ questionnaire completed 98% patients.Proportion of missing items was 0.06%.The total time needed to fill the questionnaire was ranged from 8 to 15 min.Assistance in completing the questionnaire required 4.8% patients,while 2.9% needed help in reading,and 1.9% involved writing assistance.The mean age of the selected patients was 53.8 ± 12.9 years and 54.4% were men.Average CLDQ score was 4.62 ± 1.11.Cronbach's alpha for the whole scale was 0.93.Reliability for all domains was above 0.70,except for the domain 'Activity'(0.49).The exploratory factor analysis model revealed 6 factors with eigenvalue of greater than 1,explaining 69.7% of cumulative variance.The majority of the items(66%)in the Serbian version of the CLDQ presented the highest loading weight in the domain assigned by the CLDQ developers:'Fatigue'(5/5),'Emotional function'(6/8),'Worry'(5/5),'Abdominal symptoms'(0/3),'Activity'(0/3),'Systemic symptoms'(3/5).The scales 'Fatigue' and 'Worry' fully corresponded to the original.The factor analysis also revealed that the factors 'Activity' and 'Abdominal symptoms' could not be replicated,and two new domains 'Sleep' and 'Nutrition' were established.Analysis of the CLDQ score/sub-score distribution according to disease severity demonstrated that patients without cirrhosis had lower total CLDQ score(4.86 ± 1.05)than those with cirrhosis Child's C(4.31 ± 0.97).Statistically significant difference was detected for the domains 'Abdominal symptoms' [F(3)= 5.818,P = 0.001] and 'Fatigue' [F(3)= 3.39,P = 0.021].Post hoc analysis revealed that patients with liver cirrhosis Child's C had significantly lower sub-score 'Abdominal symptoms' than patients without cirrhosis or liver cirrhosis Child's A or B.For domain 'Fatigue',patients with cirrhosis Child's C had significantly lower score,than non-cirrhotic patients.CONCLUSION:The Serbian version of CLDQ is well accepted and represents a valid and reliable instrument in Serbian sample of CLD patients. | Dusan Dj Popovic Nada V Kovacevic Darija B Kisic Tepavcevic Goran Z Trajkovic Tamara M Alempijevic Milan M Spuran Miodrag N Krstic Rada S Jesic Zobair M Younossi Tatjana D Pekmezovic | 2013 | World Journal of Gastroenterology2013，19，30： | 1 |
| 15 | Frequency of Helicobacter pylori infection in patients with liver cirrhosis显示文摘 | Alempijevic T Krstic M Antonic V | 2007 | Srp Arh Celok Lek2007，135，910： | 1 |
| 16 | Death caused by heat stroke:case report显示文摘 | Savic S Pavlekic Alempijevic D | 2014 | Srp Arh Celok Lek2014，142，56： | 1 |
| 17 | Amniotic fluid embolism-apropos two consecutive cases显示文摘 | Jecmenica D Baralic'I Alempijevic'D | 2011 | J Forensic Sci2011，56，1： | 1 |
| 18 | The role of fecal calprotectin in assessment of hepatic encephalopathy in patients with liver cirrhosis 显示文摘 | Alempijevic T Stulic M Popovic D | 2014 | Acta Gastroenterol Belg2014，77，3： | 1 |
| 19 | Gallbladder villous adenoma in a patient with acromegaly:A case report显示文摘Villous adenomas are benign epithelial lesions with malignant potential that can occur in any part of the gastrointestinal tract. We present a case of a middle age woman with acromegaly who was investigated for nonspecifi c gastrointestinal complaints. Ultrasonography and subsequent endosonography diagnosed a large (4.5 cm), hyperechoic, sessile polyp with numerous pedicles. An open cholecystectomy was performed and revealed a villous adenoma with several foci of carcinoma in situ. Detailed investigations showed no other tumors of the gastrointestinal tract. After fi ve years of follow-up, the patient reports no complaints, and the results of laboratory testing and imaging studies are within the normal range. | Miodrag Krstic Tamara Alempijevic Bojan Stimec Marjan Micev Miroslav Milicevic Dragan Micic Goran Jankovic | 2007 | World Journal of Gastroenterology2007，13，22： | 0 |
| 20 | Evaluation of Serum Cytokines Levels in Patients Undergoing Laparoscopic versus Conventional Cholecystectomy显示文摘 | Srdjan Mijatovic Branislava Stefanovic Vasilije Jeremic Slobodan Krstic Nikola Radmanovic Tamara Alempijevic Biljana Milicic Branislav Stefanovic | 2016 | Journal of Pharmacy and Pharmacology2016，4，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员